Related Experiment Video

Updated: Jun 3, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor

Levin Böhlig1, Karen Rother

  • 1Molecular Oncology, Department of Obstetrics and Gynecology, University of Leipzig, Leipzig, Germany. lboehlig@web.de

Journal of Biomedicine & Biotechnology
|March 26, 2011
PubMed

Insights

The transcription factor p53, a key tumor suppressor, can repress gene expression through various mechanisms. Understanding these repression pathways is crucial for developing new cancer therapies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Genome integrity is vital for preventing cancer, maintained by complex regulatory systems.
  • The transcription factor p53 is a critical tumor suppressor, frequently inactivated in various cancers.
  • p53's tumor-suppressive role is linked to regulating target genes, but its repressive functions are poorly understood.

Purpose of the Study:

  • To review the diverse mechanisms by which p53 acts as a transcriptional repressor.
  • To categorize p53-repressed genes based on underlying mechanisms.
  • To discuss novel regulatory roles of p53 involving noncoding RNAs.

Main Methods:

  • Literature review of p53 transcriptional repression mechanisms.
  • Classification of gene repression based on molecular pathways.
  • Inclusion of emerging research on noncoding RNA-mediated regulation.

Main Results:

  • p53 functions as a transcriptional repressor through multiple, distinct mechanisms.
  • Two primary categories of p53-repressed genes have been identified.
  • Novel mechanisms involving noncoding RNAs in p53-mediated repression are emerging.

Conclusions:

  • Elucidating p53's full spectrum of functions, including repression, is essential for understanding its tumor-suppressor activity.
  • A comprehensive understanding of p53 repression pathways is key to developing targeted cancer therapeutics.
  • Further research into noncoding RNA roles may reveal new therapeutic strategies.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...